mavacamten,
MYK-461,
Mavacamten,
MYK-461,
1642288-47-8,
UNII-QX45B99R3J,
QX45B99R3J,
Mavacamten [INN],
Mavacamten [WHO-DD],
SCHEMBL16320785,
RLCLASQCAPXVLM-NSHDSACASA-N,
EX-A2072,
SAR439152,
SB19779,
MYK-461; Mavacamten; SAR439152,
HY-109037,
CS-0031211,
(S)-3-Isopropyl-6-((1-phenylethyl)amino) pyrimidine-2,4(1H,3H)-dione,
(S)-3-Isopropyl-6-((1-phenylethyl)amino)pyrimidine-2, 4(1H,3H)-dione,
(S)-3-Isopropyl-6-(1-phenylethylamino)pyrimidine-2,4(1H,3H)-dione,
2,4(1H,3H)-Pyrimidinedione, 3-(1-methylethyl)-6-(((1S)-1-phenylethyl)amino)-,
6-(((1S)-1-Phenylethyl)amino)-3-(propan-2-yl)-1,2,3,4 tetrahydropyrimidine-2,4-dione,